Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017638 (
glioma
)
30,880
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In this study, the possible effects of
MgSO4
and lazaroid (U-83836E) on glutamate toxicity on glial cells were investigated. C6 and human glioblastoma multiforme cells derived from two patients were grown in an incubator. First, determined IC50 dose of L-glutamate (L-glu) was given for 24 hours and removed, and then respective
MgSO4
or U-83836E doses were added to the culture medium. After 24 hours 3-(4,5-Dimethylthyazol-2-yl)-2,5-diphenyltetrazolium bromide, thiazolyl blue (MTT) test was applied. When compared to the L-glu-treated group,
MgSO4
at the dose of 0.01 mM induced C6 and human
glioma
cell growth by 17%, 15% and 5%, respectively. At the dose of 1 microM U-83836E also increased C6 and human
glioma
cell growth by 12%, 13% and 5%, respectively. In conclusion, although
MgSO4
and U-83836E do not strongly block glutamate-induced cell death, it is suggested that reduction of Mg2+ ions and free radical production may have a role in glutamate toxicity on glial cells.
...
PMID:MgSO4 and lazaroid (U-83836E) partially protects glioma cells against glutamate toxicity in vitro. 1558 62